Insights from the ADVOCATE Study: Respiratory Tract Involvement in Patients with ANCA-Associated Vasculitis in a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Avacopan

被引:0
|
作者
Specks, U. [1 ]
Jayne, D. R. W. [2 ]
Merkel, P. A. [3 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Univ Cambridge, Cambridge, England
[3] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4780
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Randomized, Controlled, Double-Blind Trial on the Impact of Rosuvastatin on Sublinical Markers of Atherosclerosis in Patients with ANCA-Associated Vasculitis
    Terrier, Benjamin
    Pugnet, Gregory
    Sirieix, Marie-Emmanuelle
    Quemeneur, Thomas
    Puechal, Xavier
    Maurier, Francois
    Neel, Antoine
    Benhamou, Ygal
    Bonnotte, Bernard
    Schmidt, Jean
    Michon, Adrien
    Baudet, Antoine
    Charles, Pierre
    Cohen, Fleur
    De Moreuil, Claire
    Dernis, Emanuelle
    Belenotti, Pauline
    Ruivard, Marc
    Aumaitre, Olivier
    Fain, Olivier
    Seror, Raphaele
    Durel, Cecile-Audrey
    Jourde-Chiche, Noemie
    Lazaro, Estibaliz
    Chironi, Gilles
    Armengol, Guillaume
    Bellien, Jeremy
    Ravaud, Philippe
    Baron, Gabriel
    Guillevin, Loic
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1721 - 1723
  • [2] Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
    Pagnoux, Christian
    Neel, Antoine
    Bray, Sarah
    Gurlin, Rachel E.
    Trimpe, Darcy
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5038 - 5040
  • [3] A RANDOMIZED PHASE 3 TRIAL EVALUATING THE SAFETY AND EFFICACY OF AVACOPAN IN PATIENTS WITH NEW OR RELAPSING ANCA-ASSOCIATED VASCULITIS
    Merkel, Peter
    Jayne, David
    Harigai, Masayoshi
    Schall, Thomas
    Bekker, Pirow
    Potarca, Antonia
    Hillson, Jan
    RHEUMATOLOGY, 2019, 58
  • [4] Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis and Ear, Nose, or Throat Involvement in a Phase 3 Trial
    Spiera, Robert
    Lebovics, Robert
    Bray, Sarah
    Gurlin, Rachel E.
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5043 - 5045
  • [5] Efficacy and Safety of Avacopan in Patients with ANCA-Associated Vasculitis Receiving Rituximab in a Phase 3 Trial
    Geetha, Duvuru
    Dua, Anisha
    Yue, Huibin
    Salvarani, Carlo
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1366 - 1367
  • [6] INCIDENCE OF INFECTIONS IN THE AVACOPAN GROUP VERSUS PREDNISONE GROUP IN ANCA-ASSOCIATED VASCULITIS, RESULTS FROM THE PHASE 3 ADVOCATE STUDY
    George, Michael
    Kronbichler, Andreas
    Pagnoux, Christian
    Springer, Jason
    Westman, Kerstin W. A.
    Yue, Huibin
    Bekker, Pirow
    Degoma, Emil
    Jayne, David
    Merkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I823 - I823
  • [7] General, Nervous System, Eye, and Skin Involvement in the Phase 3 Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis
    Hajj-Ali, Rula A.
    Geetha, Duvuru
    Luqmani, Raashid
    Pagnoux, Christian
    Trimpe, Darcy
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5046 - 5047
  • [8] EFFECT OF AVACOPAN ON RELAPSE RATES AND RELAPSE-FREE TIME IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS, RESULTS OF THE PHASE 3 ADVOCATE STUDY
    Merkel, P. A.
    Yue, H.
    deGoma, E.
    Bekker, P.
    Jayne, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 120 - 120
  • [9] Efficacy and Safety of Avacopan Versus Prednisone Taper in Patients With ANCA-Associated Vasculitis With Lung Involvement: A Post Hoc Analysis of the ADVOCATE Trial
    Specks, U.
    Fussner, L. A.
    Jayne, D. R. W.
    Bray, S.
    Gurlin, R. E.
    Merkel, P. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [10] Efects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trial
    O'Neil, Joelle
    Hughes, Susan
    Lourie, Andrea
    Zweifler, John
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (04) : 384 - 388